Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,196 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04411537 | The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Jun 2, 2020 | clinicaltrials |
| NCT04403529 | Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | completed | Phase 3 | 647 | Fudan UniversityOTHER | 0 | May 19, 2020 | clinicaltrials |
| NCT01314833 | Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy | completed | Phase 3 | 1,570 | Fudan UniversityOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT04394598 | A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer | unknown | Phase 2 | 210 | Fudan UniversityOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT01026116 | A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old | completed | Phase 3 | 521 | Fudan UniversityOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04281641 | Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer(PHC-BC) | recruiting | N/A | 94 | Fudan UniversityOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | completed | Phase 3 | 647 | Fudan UniversityOTHER | 0 | Apr 24, 2020 | clinicaltrials |
| NCT03268772 | PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS | unknown | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT04351282 | SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma | unknown | N/A | 43 | Fudan UniversityOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT04340713 | The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal Therapy | completed | N/A | 95 | Fudan UniversityOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT04334785 | Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer | unknown | N/A | 186 | Fudan UniversityOTHER | 1 | Apr 6, 2020 | clinicaltrials |
| NCT04312087 | Lateral Neck Lymph Node Mapping in Thyroid Cancer | unknown | N/A | 250 | Fudan UniversityOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT04307147 | NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy | unknown | Phase 3 | 316 | Fudan UniversityOTHER | 1 | Mar 13, 2020 | clinicaltrials |
| NCT04302441 | A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy | unknown | Phase 2 | 550 | Fudan UniversityOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT02635971 | Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 168 | Fudan UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT04280666 | Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening. | unknown | — | 100 | Fudan UniversityOTHER | 1 | Feb 21, 2020 | clinicaltrials |
| NCT02636556 | Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors | completed | N/A | 56 | Fudan UniversityOTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT04248387 | Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma(FU-Name-T001) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jan 30, 2020 | clinicaltrials |
| NCT03918889 | Effect of Dexmedetomidine in Preventing Cough and Postoperative Pain After Laryngeal Surgery for Cancer | unknown | N/A | 120 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT04227886 | Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer | unknown | — | 250 | Fudan UniversityOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT04217096 | Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients | unknown | Phase 4 | 40 | Fudan UniversityOTHER | 1 | Jan 3, 2020 | clinicaltrials |
| NCT04101929 | Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen | unknown | Phase 2 | 126 | Fudan UniversityOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT02628613 | Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations | completed | Phase 2 | 91 | Fudan UniversityOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT04115618 | SIB in Upper Thoracic Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 65 | Fudan UniversityOTHER | 1 | Oct 4, 2019 | clinicaltrials |
| NCT04106180 | SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC | unknown | Phase 2 | 63 | Fudan UniversityOTHER | 1 | Sep 26, 2019 | clinicaltrials |
| NCT04066322 | Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment(RMPanNET) | unknown | — | 180 | Fudan UniversityOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT04061408 | FSRT in Breast Cancer Patients With Brain Metastases | unknown | Phase 2 | 170 | Fudan UniversityOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT01936233 | Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery | unknown | Phase 3 | 112 | Fudan UniversityOTHER | 1 | Aug 5, 2019 | clinicaltrials |
| NCT03575260 | 500mg Fulvestrant Versus Exemestane in MBC | completed | — | 120 | Fudan UniversityOTHER | 1 | Jul 30, 2019 | clinicaltrials |
| NCT04030845 | Patient Report Outcome-Reconstruction and Oncoplastic Cohort(PRO-ROC) | unknown | — | 10,000 | Fudan UniversityOTHER | 1 | Jul 25, 2019 | clinicaltrials |
| NCT04025164 | Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery | recruiting | N/A | 4,052 | Fudan UniversityOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT04012502 | De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations | unknown | N/A | 83 | Fudan UniversityOTHER | 1 | Jul 9, 2019 | clinicaltrials |
| NCT03403829 | Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage | unknown | Phase 3 | 360 | Fudan UniversityOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT04006626 | 18F-FES PET/CT's Additional Clinical Value in ER+ BC | completed | — | 19 | Fudan UniversityOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT03695341 | 500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI | completed | — | 130 | Fudan UniversityOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT03988686 | Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone | unknown | N/A | 120 | Fudan UniversityOTHER | 1 | Jun 17, 2019 | clinicaltrials |
| NCT03941561 | S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC) | recruiting | Phase 3 | 1,006 | Fudan UniversityOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT03854890 | Fluorescent Lymphography-Guided Lymphadenectomy In Laparoscopic Proctectomy | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT03949634 | Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin(PLD) | unknown | Phase 3 | 272 | Fudan UniversityOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT02736552 | Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. | withdrawn | Phase 3 | 0 | Fudan UniversityOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT03314649 | Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer | completed | — | 200 | Fudan UniversityOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT03929094 | Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | completed | Phase 3 | 160 | Fudan UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03841136 | Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer | unknown | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT03889626 | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | unknown | Phase 3 | 242 | Fudan UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT03868215 | Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis | unknown | — | 100 | Fudan UniversityOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT01831531 | Study of S-1 in Combination With Radiotherapy in Esophageal Cancer | completed | Phase 2 | 105 | Fudan UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials